世界のユーバイオティクス市場(~2027年):形態別、機能別、家畜別、種類別、地域別

【英語タイトル】Eubiotics Market Research Report by Form, Function, Livestock, Type, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

360iResearchが出版した調査資料(360iR22DC170)・商品コード:360iR22DC170
・発行会社(調査会社):360iResearch
・発行日:2022年10月
・ページ数:250
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,949 ⇒換算¥732,452見積依頼/購入/質問フォーム
Enterprise LicenseUSD9,949 ⇒換算¥1,472,452見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

360iResearch社は、2021年6,956.42百万ドルであった世界のユーバイオティクス市場規模が、2022年に8,049.51百万ドルへと拡大し、2027年までにCAGR 15.89%で成長して16,852.80百万ドルに達すると予測しています。当書は、ユーバイオティクスの世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、形態別(乾燥、液体)分析、機能別(免疫、栄養&腸健康、生産性、産出高)分析、家畜別(水生動物、家禽、反芻動物、豚)分析、種類別(水生動物、家禽、反芻動物、豚)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などの内容をまとめております。なお、当書に掲載されている企業情報には、ADDCON GmbH、Advanced BioNutrition Corp、ALLAND & ROBERT、Alltech, Inc.、BASF SE、Behn Meyer Group、Beneo Group、Calpis Co., Ltd.、Cargill Incorporated、Chr. Hansen Holding A/S、E.I. Dupont De Nemours and Company、Esseco Groupなどが含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界のユーバイオティクス市場規模:形態別
- 乾燥ユーバイオティクスの市場規模
- 液体ユーバイオティクスの市場規模
・世界のユーバイオティクス市場規模:機能別
- 免疫の市場規模
- 栄養&腸健康の市場規模
- 生産性の市場規模
- 産出高の市場規模
・世界のユーバイオティクス市場規模:家畜別
- 水生動物の市場規模
- 家禽の市場規模
- 反芻動物の市場規模
- 豚の市場規模
・世界のユーバイオティクス市場規模:種類別
- エッセンシャルオイルの市場規模
- 有機酸の市場規模
- プレバイオティクスの市場規模
- プロバイオティクスの市場規模
・世界のユーバイオティクス市場規模:地域別
- 南北アメリカのユーバイオティクス市場規模
アメリカのユーバイオティクス市場規模
カナダのユーバイオティクス市場規模
ブラジルのユーバイオティクス市場規模
...
- アジア太平洋のユーバイオティクス市場規模
日本のユーバイオティクス市場規模
中国のユーバイオティクス市場規模
インドのユーバイオティクス市場規模
韓国のユーバイオティクス市場規模
台湾のユーバイオティクス市場規模
...
- ヨーロッパ/中東/アフリカのユーバイオティクス市場規模
イギリスのユーバイオティクス市場規模
ドイツのユーバイオティクス市場規模
フランスのユーバイオティクス市場規模
ロシアのユーバイオティクス市場規模
...
- その他地域のユーバイオティクス市場規模
・競争状況
・企業情報

The Global Eubiotics Market size was estimated at USD 6,956.42 million in 2021 and expected to reach USD 8,049.51 million in 2022, and is projected to grow at a CAGR 15.89% to reach USD 16,852.80 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Eubiotics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Form, the market was studied across Dry and Liquid.

Based on Function, the market was studied across Immunity, Nutrition & Gut Health, Productivity, and Yield.

Based on Livestock, the market was studied across Aquatic Animals, Poultry, Ruminants, and Swine.

Based on Type, the market was studied across Essential Oils, Organic Acids, Prebiotics, and Probiotics. The Organic Acids is further studied across Acetic Acid, Formic Acid, Fumaric Acid, Lactic Acid, and Propionic Acid. The Prebiotics is further studied across Fructo-Oligosaccharides, Galacto-Oligosaccharides, Inulin, and Mannan-Oligosaccharide. The Probiotics is further studied across Bifidobacteria, Lactobacilli, and Streptococcus Thermophilus.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Eubiotics market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Eubiotics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Eubiotics Market, including ADDCON GmbH, Advanced BioNutrition Corp, ALLAND & ROBERT, Alltech, Inc., BASF SE, Behn Meyer Group, Beneo Group, Calpis Co., Ltd., Cargill Incorporated, Chr. Hansen Holding A/S, E.I. Dupont De Nemours and Company, Esseco Group, Kemin Industries, Inc., Kerry Group, Koninklijke DSM N.V., Lallemand, Inc., Lesaffre Group, Lonza Group AG, MSPrebiotics Inc., Novozymes A/S, and Novus International, Inc..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Eubiotics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Eubiotics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Eubiotics Market?
4. What is the competitive strategic window for opportunities in the Global Eubiotics Market?
5. What are the technology trends and regulatory frameworks in the Global Eubiotics Market?
6. What is the market share of the leading vendors in the Global Eubiotics Market?
7. What modes and strategic moves are considered suitable for entering the Global Eubiotics Market?

❖ レポートの目次 ❖

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising demand for manufactured feed
5.1.1.2. Growth in requirement for animal protein
5.1.1.3. Increasing meat consumption due to large scale meat production
5.1.1.4. Increasing investment in the pet industry
5.1.2. Restraints
5.1.2.1. Lack of essential oils availability in animal feed applications
5.1.2.2. Large financial costs associated with the production of these compounds
5.1.3. Opportunities
5.1.3.1. Increasing awareness about feed quality and safety
5.1.3.2. Investments in R&D activities for the development of superior products
5.1.3.3. Growing awareness about meat quality and dairy product
5.1.4. Challenges
5.1.4.1. Strict government regulations
5.2. Cumulative Impact of COVID-19

6. Eubiotics Market, by Form
6.1. Introduction
6.2. Dry
6.3. Liquid

7. Eubiotics Market, by Function
7.1. Introduction
7.2. Immunity
7.3. Nutrition & Gut Health
7.4. Productivity
7.5. Yield

8. Eubiotics Market, by Livestock
8.1. Introduction
8.2. Aquatic Animals
8.3. Poultry
8.4. Ruminants
8.5. Swine

9. Eubiotics Market, by Type
9.1. Introduction
9.2. Essential Oils
9.3. Organic Acids
9.4.1. Acetic Acid
9.4.2. Formic Acid
9.4.3. Fumaric Acid
9.4.4. Lactic Acid
9.4.5. Propionic Acid
9.4. Prebiotics
9.5.1. Fructo-Oligosaccharides
9.5.2. Galacto-Oligosaccharides
9.5.3. Inulin
9.5.4. Mannan-Oligosaccharide
9.5. Probiotics
9.6.1. Bifidobacteria
9.6.2. Lactobacilli
9.6.3. Streptococcus Thermophilus

10. Americas Eubiotics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Eubiotics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Eubiotics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. ADDCON GmbH
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Advanced BioNutrition Corp
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. ALLAND & ROBERT
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Alltech, Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. BASF SE
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Behn Meyer Group
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Beneo Group
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Calpis Co., Ltd.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Cargill Incorporated
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Chr. Hansen Holding A/S
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. E.I. Dupont De Nemours and Company
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Esseco Group
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Kemin Industries, Inc.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Kerry Group
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Koninklijke DSM N.V.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Lallemand, Inc.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Lesaffre Group
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Lonza Group AG
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. MSPrebiotics Inc.
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Novozymes A/S
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Novus International, Inc.
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing



★調査レポート[世界のユーバイオティクス市場(~2027年):形態別、機能別、家畜別、種類別、地域別] (コード:360iR22DC170)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のユーバイオティクス市場(~2027年):形態別、機能別、家畜別、種類別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆